Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Averest Capital is a Munich-based private equity firm that specializes in investments in medium-sized 'Mittelstand' companies within the DACH region. The firm maintains a dedicated focus on sectors including healthcare, medical technology, software, and industrial services, typically targeting businesses with revenues between €10 million and €100 million. In the healthcare space, Averest Capital focuses on medical technology manufacturers and healthcare service providers, aiming to drive growth through operational improvements and buy-and-build strategies. Notable healthcare-related portfolio companies include Mecora Medizintechnik, a provider of medical technology services, and Kardian, a cardiology service provider. The firm is led by experienced partners with backgrounds in strategy consulting and private equity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Averest Capital.